Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.22.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2022
Jan. 31, 2021
OPERATING EXPENSES        
Research and development $ 873,653 $ 234,262 $ 3,540,111 $ 1,018,021
General and administrative 1,682,913 881,397 4,906,628 2,713,891
Total operating expenses 2,556,566 1,115,659 8,446,739 3,731,912
Loss from operations (2,556,566) (1,115,659) (8,446,739) (3,731,912)
OTHER INCOME (EXPENSE), NET        
Interest expense (16,299) (57,366) (45,922) (108,181)
Interest expense - related party (8,277) (13,765)
Interest income - related party 1,706
Gain on extinguishment of debt   62,418 62,418
Total other income (expense), net (16,299) (3,225) (45,922) (57,822)
NET LOSS $ (2,572,865) $ (1,118,884) $ (8,492,661) $ (3,789,734)
Basic and diluted net loss per common share $ (0.03) $ (0.02) $ (0.09) $ (0.05)